id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0559-0055,FDA,FDA-2008-D-0559,Guidance for Industry on Process Validation; Availability: General Principles and Practices,Notice,Notice of Availability,2011-01-25T05:00:00Z,2011,1,2011-01-25T05:00:00Z,,2020-05-05T17:48:28Z,2011-01437,0,0,0900006480bd2050
FDA-2008-D-0559-0056,FDA,FDA-2008-D-0559,Guidance for Industry; Process Validation: General Principles and Practices,Other,Guidance,2011-01-24T05:00:00Z,2011,1,2011-01-24T05:00:00Z,,2020-06-26T17:16:46Z,,0,0,0900006480bd20ee
FDA-2008-D-0559-0040,FDA,FDA-2008-D-0559,Draft Guidance for Industry on Process Validation: General Principles and Practices; Reopening of Comment Period,Notice,NEC-Notice of Extension,2009-02-13T05:00:00Z,2009,2,2009-02-13T05:00:00Z,2009-03-17T03:59:59Z,2009-02-13T18:01:54Z,E9-03090,0,0,090000648085687e
FDA-2008-D-0559-0002,FDA,FDA-2008-D-0559,Guidance for Industry on Process Validation: General Principles and Practices - Draft Guidance,Other,GDL-Guidance (Supporting and Related Materials),2008-11-18T05:00:00Z,2008,11,,,2024-11-07T22:00:47Z,,1,0,09000064807afc11
FDA-2008-D-0559-0001,FDA,FDA-2008-D-0559,"Industry on Process Validation, Draft Guidance; Availability: General Principles and Practices",Notice,NAD-Notice of Availability of Data,2008-11-18T05:00:00Z,2008,11,2008-11-18T05:00:00Z,2009-01-22T04:59:59Z,2009-01-27T19:14:18Z,E8-27321,0,0,09000064807af91e